.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Papa & Barkley is stocked at 686 licensed dispensaries across California, New York, and Oregon, 519 of them in California, with the deepest coverage in Los Angeles, San Diego, San Francisco, Sacramento, and San Jose. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Papa & Barkley’s mix stayed concentrated in Topical at 51.63% share with year-over-year down 1.51% and month-over-month down 2.16%, while Tincture & Sublingual held 30.93% share with year-over-year down 7.46% and month-over-month down 2.74%. Edible expanded to 12.61% share with year-over-year up 30.02% but month-over-month down 0.22%, as Capsules slipped to 4.69% share with year-over-year down 17.80% and month-over-month down 4.57%; Concentrates remained negligible at 0.15% share with year-over-year down 30.77% and month-over-month down 47.40%. With brand-level sales year-over-year at -1.51% versus a 0.06% decline in average price, the pattern implies volume softness in legacy wellness formats offset in part by Edible growth, keeping Papa & Barkley anchored in Topical leadership while nudging mix toward lower-price Edible units.
The category shifts imply that Papa & Barkley is leaning further into pain-relief and wellness identity via Topical (rank 1 in California) even as consumer trial migrates toward Edible, where a 30.02% year-over-year lift contrasts with Topical’s 1.51% decline and Tincture & Sublingual’s 7.46% decline. Given month-over-month declines across Topical (-2.16%) and Tincture & Sublingual (-2.74%) alongside a smaller Edible dip (-0.22%), the near-term positioning signal is to defend premium Topical price architecture while reallocating activation toward Edible entry points, because the 0.06% brand-wide price decrease alongside a 1.51% sales decline indicates unit pressure that Edible momentum can absorb without eroding the Topical-led brand equity.
Competitive Landscape
Papa & Barkley sits at rank #1 in California Topical for September 2026, unchanged from #1 a year earlier, while holding #1 for the past three months and matching its peak at #1 in September 2026; by contrast, Mary's Medicinals is at #2 with a year-over-year sales decline of 40.3%, and Buddies is at #3 with a 15.9% year-over-year sales increase, indicating pressure from below even as the nearest incumbent lags. Meanwhile, Sweet ReLeaf (CA) climbed from #5 to #4 with 30.2% year-over-year growth and Carter's Aromatherapy Designs (C.A.D.) slipped from #4 to #5 despite 20.5% growth, a spread that implies Papa & Barkley’s flat rank trajectory at #1 reflects a defended lead but narrowing headroom as faster-growing challengers consolidate immediately behind.
Notable Products
THC Releaf Oil Tincture (1000mg THC, 15ml) posted the steepest decline at -18.5% month over month, slipping to rank 7 as the edible-led Sleep Releaf - CBD/CBN/THC 1:1:1 Berry Pomegranate Solventless Gummies 20-Pack (100mg CBN, 100mg CBD, 100mg THC) climbed 47.5% to rank 1. Topicals dominated concentration with five of the top ten SKUs, yet the CBD/THC 1:3 THC Rich Releaf Balm (30mg CBD, 90mg THC, 15ml, 0.5oz) fell -14.8% at rank 6 while the CBD/THC 3:1 CBD Rich Releaf Balm (90mg CBD, 30mg THC, 15ml, 0.5oz) rose 8.6% at rank 8. The mix implies Papa & Barkley is leaning into high-velocity edibles while legacy tincture demand softens, shifting revenue weight from traditional formats toward ingestibles despite topicals still anchoring shelf presence.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
